Moderna | MRNA - Gross Profit On Sales


Moderna reported $-566M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Acadia Pharmaceuticals USD 243.27M 14.49M Mar/2026
Agios Pharmaceuticals USD 19.43M 1.34M Mar/2026
Alnylam Pharmaceuticals USD 825M 4.3M Mar/2026
Amgen USD 6.89B 415M Dec/2025
Arrowhead Research USD 264.03M 7.56M Dec/2025
Biogen USD 1.82B 169.5M Mar/2026
BioMarin Pharmaceutical USD 571.21M 141.8M Mar/2026
Celltrion KRW 46.98B 579.12B Dec/2025
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Esperion Therapeutics USD 140.59M 94.57M Dec/2025
Gilead Sciences USD 5.52B 791M Mar/2026
GlaxoSmithKline GBP 5.75B 429M Mar/2026
Incyte USD 1.17B 217.51M Mar/2026
Ionis Pharmaceuticals USD 243M 48M Mar/2026
Kangmei Pharma CNY 238.34M 31.95M Mar/2026
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Moderna USD -566M 792M Mar/2026
Organigram Holdings CAD 23.32M 8.52M Dec/2025
Pharma Mar EUR 39.24M 47.46M Mar/2026
Puma Biotechnology USD 20.32M 24.85M Sep/2024
Qiagen NV USD 325.27M 19.53M Dec/2025
Regeneron Pharmaceuticals USD 2.94B 363.7M Mar/2026
Sangamo BioSciences -2.39M 1.09M Jun/2024
Sarepta Therapeutics USD 621.34M 577.79M Mar/2026
Sartorius EUR 414.5M 18.3M Mar/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Tilray USD 57.47M 10.16M Jun/2025
Ultragenyx Pharmaceutical USD 106M 72M Mar/2026
United Therapeutics USD 315.5M 286.6M Dec/2025
Vertex Pharmaceuticals USD 2.6B 121.7M Mar/2026
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026